Grant: Discovery Grants Program - Individual
University of Waterloo
$20,000.00
Integrating biological and engineering approaches to maximize the utility of baculoviruses as gene delivery vehicles
EF 2013-14
Résumé
The demand for biologics is increasing at an unprecedented rate. US demand alone for biologics is expected to go beyond $100 billion/year by 2015. Animal cell culture is the major platform for high value biologics production, with Chinese Hamster Ovary cells having dominated the bioprocess industry for many years. Insect cells, however, offer many advantages over mammalian cells. These advantages include: not propagating human or mammalian specific viruses; being grown in suspension culture to high cell densities without the presence of serum in the media - eliminating a potential source of prion and mammalian virus contamination; and, in combination with the baculovirus expression vector system (BEVS), allowing high levels of protein expression.This research program aims to further insect cell culture as an alternative production platform by enhancing the control over protein expression and by enabling a better understanding of insect cell metabolism. Fine control over protein expression will be achieved through the manipulation of genetic promoter sequences. Optimal combinations will lead to the creation of new expression vectors that can be used as platform technologies for the optimal production of biologics. To further enhance the environment used to produce these biologics, metabolomics will be used to refine and expand existing metabolic models of insect cells. With this approach, feeding profiles will be developed for production at high cell densities, leading to greater and more consistent yields of biologics. These advances will come with the training of 9 students: 4 PhD students and 5 undergraduates. These students will become highly qualified in the area of bioprocessing and will be familiar with all aspects of biologics production: from manipulating DNA to product purification.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
355513-2012
Name nom
Aucoin, Marc
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
2
Nb partie
5
Application title
Integrating biological and engineering approaches to maximize the utility of baculoviruses as gene delivery vehicles
Keyword
NSERC
Application summary
The demand for biologics is increasing at an unprecedented rate. US demand alone for biologics is expected to go beyond $100 billion/year by 2015. Animal cell culture is the major platform for high value biologics production, with Chinese Hamster Ovary cells having dominated the bioprocess industry for many years. Insect cells, however, offer many advantages over mammalian cells. These advantages include: not propagating human or mammalian specific viruses; being grown in suspension culture to high cell densities without the presence of serum in the media - eliminating a potential source of prion and mammalian virus contamination; and, in combination with the baculovirus expression vector system (BEVS), allowing high levels of protein expression.This research program aims to further insect cell culture as an alternative production platform by enhancing the control over protein expression and by enabling a better understanding of insect cell metabolism. Fine control over protein expression will be achieved through the manipulation of genetic promoter sequences. Optimal combinations will lead to the creation of new expression vectors that can be used as platform technologies for the optimal production of biologics. To further enhance the environment used to produce these biologics, metabolomics will be used to refine and expand existing metabolic models of insect cells. With this approach, feeding profiles will be developed for production at high cell densities, leading to greater and more consistent yields of biologics. These advances will come with the training of 9 students: 4 PhD students and 5 undergraduates. These students will become highly qualified in the area of bioprocessing and will be familiar with all aspects of biologics production: from manipulating DNA to product purification.